Target finder


Insert sequence accession number

Cancel

Record ID: NRN_CS182176

Description:Sequence 3 from Patent EP1588718. Therapeutic and preventive agent for allodynia. MEDICAMENT AND METHOD FOR AMELIORATIONG BRAIN FUNCTION. Lymphangiogenesis accelerator. Hepatocyte Growth Factor Gene Therapy to Enhance Musculocutaneous Flap Survival. Lymphangiogenesis accelerator. Sequence 3 from patent US 7790692.
Length:5181 bp
Found in databases: nrnl1
Found in the following 5 patents: EP1588718 (lens, espacenet) WO2007013603 (lens, espacenet) JP2005314404 (lens, espacenet) JP2008163007 (lens, espacenet) US7790692 (lens, espacenet)

2 amplicons

View all records targeted by these methods

View these methods in JRC GMO-Matrix



0 518 1036 1554 2072 2591 3109 3627 4145 4663 5181 QL-ELE-00-002 QL-ELE-00-003

Legend

Event-specific method
Element-specific method
Construct-specific method
Taxon-specific method

Record ID Database Record description Record length Taxon Method Amplicon size Match details
NRN_CS182176 nrnl1 Sequence 3 from Patent EP1588718. ... 5181 bp unidentified QL-ELE-00-002 215 bp View
NRN_CS182176 nrnl1 Sequence 3 from Patent EP1588718. ... 5181 bp unidentified QL-ELE-00-003 173 bp View


Related publications:

Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101. 

Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.